The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.
The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC). Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).
The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.
We are seeking a Predoctoral Researcher for our institute.
RESEARCH DESCRIPTION
The Acute Lymphoblastic Leukemia Group at IJC Hospital Germans Trias i Pujol is a translational research group trying to develop better treatments for ALL patients. For this, we perform genomic analyses of adult ALL patients enrolled in national clinical trials from the PETHEMA Group to, from one side, precisely assess the risk of relapse and select the best therapy available, and from another side, identify new potential biomarkers and drug targets applicable in next clinical trials. This implies genetic analyses but also basic research (i.e., functional analyses in cell culture assays) to test hypotheses extracted from patients’ genetic and clinical data.
MAIN RESPONSABILITIES
* Analysis of bone marrow and peripheral blood adult ALL patients’ samples by genetic (i.e., FISH, real-time PCR) and genomic approaches (i.e., SNP array, Next Generation Sequencing, Optical Genome Mapping) from patients enrolled in PETHEMA trials from all Spain.
* Analysis and integration of multiomic data, database creation and maintenance.
* Set up of genetic tests for diagnosis and measurable residual disease assessments to be applied in future PETHEMA trials.
WHAT WE NEED
* We are looking for a hematologist (Physician) with clinical but also laboratory knowledge of the disease (cytomorphology, flow cytometry, genetics).
* Experience in molecular biology and multiomic data analysis.
* Motivation in biomedical research, proactivity, creativity, team building and collaboration.
* Availability to work independently will be highly appreciated.
* Good communication skills, especially in English, will be needed to present data in international hematology congresses.
WHAT WE OFFER
* Full-time contract.
* The opportunity to contribute to cutting-edge translational research projects in the stimulating environment of the Josep Carreras Leukaemia Research Institute.
* The stimulating environment of the Barcelona metropolitan area.
* Opportunity for professional growth in an advanced research environment.
DEADLINE
Please submit your application by April 7th, 2025.
WHO WE ARE?
What makes us different?
The mission of the Josep Carreras Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases.
The IJC’s vision is to be a world-class reference and excellent research multicampus that contributes to the improvement of results, and the cure of patients affected by leukemia and other malignant hemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.
HR Excellence
In 2019, IJC was honored with the “Human Resources Excellence in Research Award” by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers. The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities.
The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and environment for their professional development.
The IJC is an equal-opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.
#J-18808-Ljbffr